What does Heartseed Inc. do?
Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company's lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic…
What is Heartseed Inc.'s P/E and P/B ratio?
Heartseed Inc. has a P/E ratio of 379.0 and a P/B ratio of 10.88.
What is Heartseed Inc.'s debt-to-equity ratio?
Heartseed Inc. has a debt-to-equity ratio of 0.00.
How much does Heartseed Inc. owe compared with what it owns?
Heartseed Inc. owes ¥0.05 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is Heartseed Inc.'s Positivity rank?
Heartseed Inc. is ranked #9,309 of 10,750 companies globally and #3,550 of 3,683 in Japan on PositoAI, with a Positivity Score of 17,104.
Does Heartseed Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Heartseed Inc..
Where can I read the latest news about Heartseed Inc.?
Recent headlines about Heartseed Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Heartseed Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Heartseed Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.